Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: ASAIO J. 2021 Jun 1;67(6):601–610. doi: 10.1097/MAT.0000000000001432

Table 1:

Indications/Contraindications for Adult VV ECMO

Common indications for venovenous extracorporeal membrane oxygenation

One or more of the following:
  1) Hypoxemic respiratory failure (PaO2/FiO2 < 80 mmHg)*, after optimal medical management, including, in the absence of contraindications, a trial of prone positioning.
  2) Hypercapnic respiratory failure (pH <7.25), despite optimal conventional mechanical ventilation (respiratory rate 35 bpm and plateau pressure [Pplat] ≤ 30 cmH2O).
  3) Ventilatory support as a bridge to lung transplantation or primary graft dysfunction following lung transplant.

Specific clinical conditions:
 • Acute respiratory distress syndrome (e.g. viral / bacterial pneumonia, aspiration)

 • Acute eosinophilic pneumonia

 • Diffuse alveolar hemorrhage or pulmonary hemorrhage

 • Severe asthma

 • Thoracic trauma (e.g. traumatic lung injury, severe pulmonary contusion)

 • Severe inhalational injury

 • Large bronchopleural fistula

 • Peri-lung transplant (e.g. primary lung graft dysfunction, bridge to transplant)

Relative contraindications for venovenous extracorporeal membrane oxygenation (VV ECMO)

 • Central nervous system hemorrhage

 • Significant central nervous system injury

 • Irreversible and incapacitating central nervous system pathology

 • Systemic bleeding

 • Contraindications to anticoagulation

 • Immunosuppression

 • Older age (increasing risk of death with increasing age, but no threshold is established)

 • Mechanical ventilation for more than 7 days with Pplat > 30 cmH2O and FiO2 > 90%
*

Clinical trials have utilized several cut-off points for the indication of the start of VV ECMO: PaO2/FiO2 <80 mmHg [EOLIA Trial1], Murray Score >3 [CESAR Trial2], without strong data indicating the superiority of any one.